Viewing Study NCT01639261


Ignite Creation Date: 2025-12-24 @ 12:03 PM
Ignite Modification Date: 2026-02-08 @ 4:21 AM
Study NCT ID: NCT01639261
Status: UNKNOWN
Last Update Posted: 2012-07-12
First Post: 2012-07-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase II Trial on Treatment of Steroid-refractory Bronchiolitis Obliterans With Interferon Gamma 1b After Allogeneic SCT
Sponsor: University Hospital Regensburg
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Steroid-refractory Bronchiolitis Obliterans View
Keywords:

Keywords

Keyword Brief Keyword Text View
None steroid-refractory View
None bronchiolitis obliterans View
None allogeneic stem cell transplantation View
None interferon gamma View